Metastatic Breast Cancer

Latest News


Latest Videos


More News

A patient with metastatic breast cancer recalls the emotional experience of being among the thousands of attendees who gave a standing ovation in an auditorium in Chicago when the results of the phase 3 DESTINY-Breast04 trial — which recently led to the FDA approval of Enhertu in HER2-low disease — were presented at the 2022 ASCO Annual Meeting.

This year, I returned to the American Society of Clinical Oncology meeting, where I heard about the latest advancements in cancer care, as well as met with fellow patients and advocates.

At first, I was apprehensive about a male doctor treating my breast cancer, but I soon realized that he was treating me as he would his own family members — and that made me realize that I was in good hands.

I typically don’t use cancer labels, such as “survivor” or “thriver,” but when I heard about COVID-19 “long-haulers,” the term resonated with me.

I hope every patient and their family can feel the caring that two angels standing by a shoulder can bring.